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Social disadvantage across the life course is associated with a greater risk of coronary heart disease (CHD)
and with established CHD risk factors, but less is known about whether novel CHD risk factors show the
same patterns. The Medical Research Council National Survey of Health and Development was used to
investigate associations between occupational socioeconomic position during childhood, early adulthood
and middle age and markers of inﬂammation (C-reactive protein, interleukin-6), endothelial function (E-
selectin, tissue-plasminogen activator), adipocyte function (leptin, adiponectin) and pancreatic beta cell
function (proinsulin) measured at 60e64 years. Life course models representing sensitive periods,
accumulation of risk and social mobility were compared with a saturated model to ascertain the nature
of the relationship between social class across the life course and each of these novel CHD risk factors.
For interleukin-6 and leptin, low childhood socioeconomic position alone was associated with high risk
factor levels at 60e64 years, while for C-reactive protein and proinsulin, cumulative effects of low so-
cioeconomic position in both childhood and early adulthood were associated with higher (adverse) risk
factor levels at 60e64 years. No associations were observed between socioeconomic position at any life
period with either endothelial marker or adiponectin. Associations for C-reactive protein, interleukin-6,
leptin and proinsulin were reduced considerably by adjustment for body mass index and, to a lesser
extent, cigarette smoking. In conclusion, socioeconomic position in early life is an important determinant
of several novel CHD risk factors. Body mass index may be an important mediator of these relationships.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/3.0/).1. Introduction
In the UK and other Western countries, social disadvantage
across the life course is a strong determinant of coronary heart
disease (CHD) risk [1e3]. Potential explanations for this socioeco-
nomic gradient in CHD risk have centred on socioeconomic differ-
ences in the distribution of established risk factors, particularly
cigarette smoking, blood pressure, blood lipids and adiposity [4,5].h Institute, St George's, Uni-
E, United Kingdom.
up).
r Ireland Ltd. This is an open accesThese investigations have included a small number of studies that
have examined the effect of socioeconomic position across the life
course on established CHD risk factors, such as body mass index,
blood pressure and cholesterol [6,7]. However, a substantial
amount of variation in CHD is not explained by adjustment for
these established risk factors [4,5].
More recently, several novel risk factors have been identiﬁed as
potential predictors of increased CHD risk. These include higher
levels of markers of the inﬂammatory response, C-reactive protein
and interleukin-6, higher levels of markers of endothelial function,
E-selectin and tissue plasminogen activator, the adipokine leptin
and the pancreatic beta cell function marker proinsulin [8e13]. In
contrast, circulating levels of the adipokine adiponectin are
inversely associatedwith CHD risk [14,15]. There is growing interests article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
R. Jones et al. / Atherosclerosis 238 (2015) 70e76 71in the possibility that these novel CHD risk factors, particularly
inﬂammatory markers, may be mediators of the association be-
tween socioeconomic position and CHD risk [16e20]. Recent evi-
dence suggests that markers of endothelial, adipocyte and
pancreatic beta-cell function could also represent biological path-
ways relating socioeconomic position and CHD risk [21,22].
There is also growing evidence that low socioeconomic position
in early life, as well as in adulthood, is associated with CHD risk
[23]; which could be mediated through elevated circulating in-
ﬂammatory markers [6,24]. Several different life course models
have been advanced to deﬁne how socioeconomic position at
different stages over the life course may be related to CHD risk [25].
The sensitive (or critical) period model maintains that exposure to
risk during a particular stage in life (e.g. childhood) has an adverse
effect on health with little or no inﬂuence of the risk factor in
question outside the speciﬁed time period. The accumulation of
risk hypothesis, on the other hand, proposes that the impact of the
exposure is cumulative over the life course and that the longer an
individual is exposed to the risk in question, the greater the adverse
impact on health. Some researchers have highlighted the possible
importance of social mobility [26]. However, to our knowledge no
previous studies have examined which life course model best de-
scribes the associations between socioeconomic position at
different stages of the life course and novel CHD risk factor patterns
in middle age, when CHD risk is high.
We therefore investigated the relationship between socioeco-
nomic position and novel CHD risk factorse particularly markers of
inﬂammation and endothelial function, adipocyte and pancreatic
beta cell functionemeasured at the most recent age these markers
were measured (60e64 years) in participants of a British birth
cohort study. Socioeconomic position was based on occupational
social class assessed prospectively at three separate points during
the life course (in childhood, early adulthood and middle age). We
used a structured modelling approach [27] to assess whether
observed associations are best explained by sensitive period,
accumulation of risk or social mobility models. We also examined
whether cigarette smoking and adiposity are important mediators
of associations between socioeconomic position over the life course
and these novel CHD risk factors.2. Methods
2.1. Study design
The UK Medical Research Council (MRC) National Survey of
Health and Development is a study of a nationally representative
sample of 5362 births of all the single, legitimate births that took
place in one week in March 1946 in England, Scotland and Wales
[28]. Participating men and women have been followed up at
regular intervals between birth and later middle age [28]. Between
2006 and 2011 (at 60e64 years of age), 2856 eligible study mem-
bers (those still alive and with a known address in England, Scot-
land or Wales) were invited for an assessment at one of six clinical
research facilities or to be visited by a research nurse at home. Full
details have been reported elsewhere [27]. Invitations were not
sent to those who had died (778), were living abroad (570), had
previously withdrawn from the study (594) or had been lost to
follow-up (564). Of those invited, 2229 (78%) were assessed: 1690
attended a clinical research facility and the remaining 539 were
seen at home [29]. Physical measurements of weight and height
were made and body mass index calculated; blood pressure was
measured and a blood sample collected after an overnight fast.2.2. Novel CHD risk factors
C-reactive protein, interleukin-6, E-selectin, tissue plasminogen
activator, proinsulin, leptin and adiponectin were measured at
60e64 years of age. Blood samples were taken during the clinic or
home visit and aliquots stored at 80 C before being couriered
monthly on dry ice to the Medical Research Council Human
Nutrition Research laboratory in Cambridge, where C-reactive
proteinwas analysed according to standardised protocols. Analyses
of interleukin-6, E-selectin, tissue plasminogen activator, proinsu-
lin leptin and adiponectin were undertaken by the British Heart
Foundation Research Centre in Glasgow using serum and plasma
aliquots stored at 70 C. Details of assays and inter-assay co-
efﬁcients of variation are provided in Supplementary Table 1.
Values lower than the detection limit (1.1 mg/l for C-reactive pro-
tein, 1.0 ng/ml for E-selectin and 3.6 pmol/l for proinsulin) were
assigned a notional value equal to the detection limit divided by the
square root of 2 [30]. Measures of proinsulin were included in an-
alyses only if the studymember was recorded as having fasted prior
to blood being taken.
2.3. Socioeconomic position
Measures of occupational socioeconomic position at three
equally spaced time points over the life course were selected for
analysis. The husband's occupation (or last job if unemployed, ill or
dead) when the study member was aged 4 was chosen to represent
childhood socioeconomic position, while own occupation-based
socioeconomic position at ages 26 and 53 represented socioeco-
nomic position in early adulthood and middle age respectively.
Wherever possible, missing values were imputed from adjacent
ages (33 values from age 11 and 14 values from age 15 for childhood
socioeconomic position; 107 values from age 36 for early adult-
hood; 107 values from age 43 for late adulthood). Within the Na-
tional Survey of Health and Development, occupational
socioeconomic position is recorded using the Registrar General's
six-level classiﬁcation scheme [31]. For the purposes of our ana-
lyses, we re-categorised this measure into four levels: professional
and intermediate (I and II); skilled non-manual (IIInm); skilled
manual (IIIm); and semi-skilled and unskilled manual (IV and V).
2.4. Covariates
Bodymass index (kg/m2) was calculated fromheight andweight
measured at ages 4, 53 and 60e64 years and from self-reported
height and weight at age 26. Self-reported smoking habits were
used to calculate two measures of smoking: (1) current smoking at
age 60e64, classiﬁed in ﬁve categories: never smoked, ex-smoker
and light, medium or heavy current smoker (1e10, 11e20, or 20þ
cigarettes per day respectively) and (2) Cigarette pack years, a
measure of intensity and duration of smoking, estimated from
number of cigarettes smoked per day at ages 20, 25, 31, 36, 43, and
53 years [32].
2.5. Statistical analysis
Initially, associations between socioeconomic position and the
novel CHD risk factors were investigated using separate linear
regression models for socioeconomic position during childhood
(aged 4), early adulthood (aged 26) and middle age (aged 53). All
novel risk factors were positively skewed and therefore trans-
formed using the natural logarithm. Association between socio-
economic position and CHD risk factors did not vary markedly
between men and women, therefore these analyses were per-
formed on data on men and women combined, adjusting for sex.
R. Jones et al. / Atherosclerosis 238 (2015) 70e7672We then used a structured modelling approach to select the life
course models which best ﬁtted the data for each CHD risk factor.
The life course socioeconomic position models considered were as
follows: (1) sensitive periods in either childhood, early adulthood
or middle age; (2) accumulation of risk of low social class in
childhood and early adulthood, in adulthood only, and across all
three time points; and (3) upward or downward social mobility in
adulthood only and social mobility between any of the three time
points. To avoid zero cell counts, socioeconomic position at each
time period was further collapsed into binary indicators repre-
senting manual or non-manual occupation. Model speciﬁcation
and constraints are described in more detail in Supplementary
Table 2.
The selection of the best model has been described elsewhere
[7,27]. Brieﬂy, for each CHD risk marker, each life course model was
compared to a more complex ‘saturated’ model where parameters
are included for socioeconomic position at each time point, all two-
way interactions and the three-way interaction, using F tests. If the
F test was not statistically signiﬁcant (p > 0.05), then there was no
evidence that the more complex model explained the data better
than the simpler life course model and the latter was adopted. For
each CHD risk marker, the highest p-value for a given life course
model was chosen as the best ﬁtting model, unless the p-value for
the ‘no effect’ model was >0.05, indicating that there was no as-
sociation between socioeconomic position at any time period with
that cardiac outcome.
We then ﬁtted the identiﬁed best ﬁtting life course model to
obtain estimates of percentage differences in that speciﬁed novelTable 1
Summary statistics of the sample, National Survey of Health and Development 1946e20
N All (N ¼ 2077)
Novel coronary heart disease risk factors (age 60e64) e geometric mean (SD)
C-Reactive protein (mg/l) 2063 2.31 (2.43)
Interleukin-6 (pg/ml) 2049 2.08 (2.03)
E-selectin (ng/ml) 2049 35.35 (1.57)
Tissue-plasminogen activator (ng/ml) 1795 8.51 (1.85)
Proinsulin (pmol/l) 1795 8.82 (2.03)
Leptin (ng/ml) 2053 12.56 (2.56)
Adiponectin (mg/ml) 2051 11.77 (2.06)
Socioeconomic positiona e N (%)
Childhood (age 4)
I and II
1975
508 (25.7)
IIInm 396 (20.0)
IIIm 571 (28.9)
IV and V 500 (25.3)
Early adulthood (age 26)
I and II
1981
689 (34.8)
IIInm 624 (31.5)
IIIm 391 (19.7)
IV and V 277 (14.0)
Middle age (age 53)
I and II
2000
962 (48.1)
IIInm 467 (23.4)
IIIm 306 (15.3)
IV and V 265 (13.3)
Body mass index emean (SE)
Age 4 (kg/m2) 1799 16.18 (1.64)
Age 26 (kg/m2) 1821 22.67 (2.91)
Age 53 (kg/m2) 1965 27.13 (4.51)
Age 60e64 (kg/m2) 2071 27.86 (4.88)
Cigarette smoking
Pack years to age 53e mean (SE) 1660 9.99 (0.33)
At age 60e64 e N (%)
Never smoked 1889 911 (48.2)
Ex-smoker 773 (40.9)
Light current smoker 72 (3.8)
Moderate current smoker 99 (5.2)
Heavy current smoker 34 (1.8)
a Socioeconomic position: I and II ¼ professional and intermediate; IIInm ¼ skilled noCHD risk factor for the relevant difference in socioeconomic posi-
tion. In order to establish whether associations between low so-
cioeconomic position and adverse levels of novel risk markers
could be explained by either adiposity or smoking, covariates rep-
resenting current adiposity (body mass index at age 60e64),
adiposity over the life course (body mass index at ages 4, 26 and
53), current smoking (age 60e64), and life course smoking (ciga-
rette pack years from age 20e53) were added in turn and then
simultaneously to the best-ﬁtting life course socioeconomic posi-
tion model for each novel cardio-metabolic risk factor.
All analyses were initially restricted to participants who had
complete data on the risk factor in question, life course socioeco-
nomic position trajectory and all of the covariates, but to investigate
possible bias due to missing data the models were also reﬁtted
using multiple imputation. As well as the measures in the analysis
models, the imputation model also included the following: birth
weight; body mass index at ages 2, 6, 7, 11, 15, 20, 36 and 43 years;
blood pressure at ages 36, 43, 53 and 60e64 years; number of
cigarettes smoked per day at ages 20, 25, 31, 36, 43 and 53 years;
E-selectin, adiponectin, triglycerides, glucose, insulin, glycated he-
moglobin (HbA1c), cholesterol, high-density lipoprotein-choles-
terol andwaist-to-hip ratio at age 60e64 years; and response at the
2006e2010 data collection. Participants who died prior to or during
the 2006e2010 data collection were excluded from the imputation
process. Fifty imputed datasets were obtained via chained equa-
tions using 50 cycles per dataset [32]. All analyses were performed
using Stata 12 (StataCorp 2011). Sensitivity analyses were also
conducted to examine the effects of using socioeconomic position11.
Men (N ¼ 1010) Women (N ¼ 1067) p Value gender difference
2.24 (2.46) 2.39 (2.41) 0.087
2.15 (2.02) 2.01 (2.05) 0.033
36.81 (1.56) 34.02 (1.57) <0.001
9.09 (1.84) 7.98 (1.85) <0.001
10.06 (2.08) 7.78 (1.93) <0.001
7.53 (2.16) 20.35 (2.29) <0.001
8.55 (2.00) 15.91 (1.85) <0.001
247 (25.5) 261 (25.9) 0.93
189 (19.5) 207 (20.5)
283 (29.2) 288 (28.6)
248 (25.6) 252 (25.0)
392 (40.7) 297 (29.1) <0.001
145 (15.1) 479 (47.0)
304 (31.6) 87 (8.5)
121 (12.6) 156 (15.3)
556 (56.6) 406 (39.9) <0.001
103 (10.5) 364 (35.8)
234 (23.8) 72 (7.1)
90 (9.2) 175 (17.2)
16.31 (1.67) 16.06 (1.61) 0.0014
23.19 (2.73) 22.19 (2.99) 0.0000
27.24 (3.75) 27.02 (5.11) 0.2959
27.91 (4.10) 27.80 (5.51) 0.6153
11.54 (0.50) 8.49 (0.42) 0.0000
385 (42.0) 526 (54.1) <0.001
434 (47.4) 339 (34.8)
31 (3.4) 41 (4.2)
42 (4.6) 57 (5.9)
24 (2.6) 10 (1.0)
n-manual; IIIm ¼ skilled manual; IV and V ¼ partly skilled or unskilled.
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36 years and age 53 with 43 years).3. Results
Of the 2229 participants, 2077 (93.2%) with data available for at
least one novel CHD risk factor and a measure of socioeconomic
position for at least one of the three time periods, were included in
the initial analyses. A summary of the novel CHD risk factors at age
60e64 years and socioeconomic position, body mass index and
smoking over the life course for these participants are presented in
Table 1.3.1. Associations between socioeconomic position and the novel
CHD risk factors at different stages of the life course
We found strong evidence for associations between socioeco-
nomic position and six of the seven novel CHD risk factors; in-
dividuals in lower socioeconomic position displayed more adverse
levels of C-reactive protein, interleukin-6, E-selectin, proinsulin,
leptin and adiponectin (Table 2). The inﬂammatory markers C-
reactive protein and interleukin-6 were both associated with so-
cioeconomic position in childhood, early adulthood and middle
age. Leptin and proinsulin were associated with socioeconomic
position in childhood and early adulthood, though less clearly in
middle-age; E-selectin and adiponectin were associated with
childhood but not adult socioeconomic position. Socioeconomic
position showed no association with tissue plasminogen activator
at any stage of the life course. The associations observed were
similar in men and women with no consistent evidence for in-
teractions involving sex (data not shown).Table 2
Sex and age-adjusteda percentage differences (95% CI) in novel coronary heart disease (C
(reference group).b
Inﬂammatory and endothelial markers
C-reactive protein Interleukin-6 E-selectin Tissue pl
(N ¼ 2063) (N ¼ 2049) (N ¼ 2049) (N ¼ 179
Childhood
I and II e e e e
IIInm 3.2 7.9 7.1 4.0
(8.5 to 14.8) (1.4 to 17.3) (1.2e13.0) (4.6 to
IIIm 22.6 20.5 7.1 6.8
(12.0e33.2) (12.0e29.0) (1.8e12.5) (1.0 to
IV and V 25.1 17.6 8.0 4.9
(14.2e36.1) (8.8e26.4) (2.4e13.5) (3.3 to
Trend p <0.001 <0.001 0.002 0.171
Early adulthood
I and II e e e e
IIInm 13.8 8.9 1.7 2.0
(3.8e23.8) (0.8e16.9) (6.7 to 3.4) (9.3 to
IIIm 16.2 7.7 1.7 5.7
(5.1e27.3) (1.3 to 16.7) (4.0 to 7.3) (2.6 to
IV and V 36.2 22.3 5.4 2.5
(23.8e48.7) (12.3e32.3) (1.0 to 11.7) (6.8 to
Trend p <0.001 <0.001 0.104 0.271
Middle age
I and II e e e e
IIInm 16.0 14.1 0.9 1.8
(5.7e26.2) (5.9e22.3) (6.1 to 4.3) (5.7 to
IIIm 11.0 6.3 1.4 2.1
(0.5 to 22.5) (2.9 to 15.6) (4.4 to 7.3) (6.6 to
IV and V 26.6 15.2 1.2 7.6
(14.4e38.8) (5.4e25.1) (5.1 to 7.4) (16.9 to
Trend p <0.001 0.002 0.579 0.355
a Age at blood draw (60e64 years).
b Socioeconomic position: I and II ¼ professional and intermediate; IIInm ¼ skilled no3.2. Comparison of life course models
In order to compare model ﬁt of the different life course models,
the sample was restricted further to cohort members who had
measures of socioeconomic position at all three time points
(n¼ 1840, 88.6%). Details of participant numbers andmean levels of
the CHD risk factors for each of the eight possible trajectories of
socioeconomic position are presented in Supplementary Table 3,
while the results of model ﬁtting are presented in Table 3. The
childhood sensitive period model provided the best model ﬁt for
both interleukin-6 and leptin (p-values: 0.856, 0.936 respectively),
while the childhood and early adult accumulation model offered
the best ﬁt for C-reactive protein and proinsulin (p values: 0.701,
0.360) (Table 3). For E-selectin, tissue plasminogen activator and
adiponectin, the ‘no effect’ model provided the best ﬁt and
regression estimates were non-signiﬁcant for all life coursemodels;
consequently they were omitted from further analyses.
Details of the selected life course models for C-reactive protein,
interleukin-6, proinsulin and leptin, controlling for sex, arepresented
in Table 4. Interleukin-6 and leptin were respectively 12.2% (95% CI:
4.0e20.4) higher and 16.7% (95% CI: 7.6e25.9) higher among in-
dividuals with manual compared to those with non-manual child-
hood socioeconomic position after adjustment for sex. C-reactive
protein increasedby16.3% (95%CI: 9.6e23.0) andproinsulinby10.7%
(95% CI: 5.3e16.1) for each unit increase in early life socioeconomic
position score (on a scale from 0 to 2, with 2 indicating manual so-
cioeconomic position in both childhood and early adulthood).
3.3. Adjustment for adiposity and cigarette smoking: sensitivity
analyses
The effects of adjustment for current and life course body mass
index and cigarette smoking of these associations betweenHD) risk markers for lower socioeconomic position relative to the highest position
Pancreatic and adiposity markers
asminogen activator Proinsulin Leptin Adiponectin
5) (N ¼ 1795) (N ¼ 2053) (N ¼ 2051)
e e e
3.4 12.4 9.5
12.5) (6.2 to 13.0) (1.9e22.9) (18.1 to 0.9)
19.9 22.6 11.8
14.6) (11.1e28.7) (13.1e32.2) (19.7 to 3.9)
19.1 21.9 10.9
13.0) (9.9e28.3) (12.0e31.8) (19.0 to 2.7)
<0.001 <0.001 0.013
e e e
4.1 16.2 2.6
5.4) (4.2 to 12.4) (7.2e25.2) (10.0 to 4.9)
17.8 12.3 9.8
14.0) (8.5e27.2) (2.2e22.4) (18.1 to 1.6)
16.8 13.5 3.1
11.8) (6.2e27.3) (2.3e24.8) (12.3 to 6.2)
<0.001 0.007 0.155
e e e
4.9 15.6 0.7
9.4) (3.7 to 13.4) (5.4e26.8) (6.9 to 8.3)
6.5 9 0.4
10.7) (3.3 to 16.3) (1.8 to 20.9) (8.9 to 8.2)
7.6 12.7 3.0
1.6) (2.9 to 18.1) (0.9e25.9) (12.2 to 6.1)
0.035 0.090 0.386
n-manual; IIIm ¼ skilled manual; IV and V ¼ partly skilled or unskilled.
Table 3
P-values from partial F tests comparing each life course model relating socioeconomic position and CHD risk markers with the saturated model.a
Life course social class model Inﬂammatory and endothelial markers Pancreatic and adiposity markers
C-reactive protein
(N ¼ 1827)
Interleukin-6
(N ¼ 1818)
E-selectin
(N ¼ 1818)
Tissue plasminogen
activator (N ¼ 1601)
Proinsulin
(N ¼ 1601)
Leptin
(N ¼ 1822)
Adiponectin
(N ¼ 1820)
No effect 0.000 0.001 0.314 0.220 0.000 0.010 0.313
Sensitive period models
Childhood (age 4) 0.125 0.856 0.684 0.259 0.115 0.936 0.723
Early adulthood (age 26) 0.003 0.008 0.556 0.288 0.001 0.011 0.473
Middle age (age 53) 0.000 0.003 0.259 0.218 0.000 0.012 0.256
Accumulation models
Childhood and early adulthood 0.701 0.625 0.868 0.359 0.297 0.352 0.830
Early adulthood and middle age 0.001 0.009 0.414 0.151 0.000 0.015 0.376
Whole life 0.163 0.258 0.666 0.182 0.006 0.184 0.632
Social mobility models
Adulthood (age 26 & 53) 0.000 0.001 0.260 0.339 0.000 0.006 0.251
Whole life 0.000 0.006 0.295 0.316 0.000 0.085 0.554
Bold indicates p-value > 0.05.
a Larger p values represent better model ﬁt. Shaded cells indicate the selected model e the most parsimonious model with a good ﬁt to the data.
R. Jones et al. / Atherosclerosis 238 (2015) 70e7674socioeconomic position and novel CHD risk factors are shown in
Table 4. Adjustment for current and life course body mass index
attenuated the associations observed between socioeconomic posi-
tion and four CHD risk factors (C-reactive protein, interleukin-6,
proinsulin and leptin); only the association between socioeconomic
position and C-reactive protein remaining statistically signiﬁcant
(Table 4). Attenuation was similar, but less marked, when adjusting
for current and life course smoking, with the exception of associa-
tionswith proinsulin and leptinwhichwere slightly strengthened by
adjustment for current smoking status. Additional adjustment for
systolic blood pressure, diastolic blood pressure and LDL cholesterol,
both singlyandsimultaneously, hadnomaterial effectson theResults
(data not shown), so were not included in the analysis.
Sensitivity analyses were carried out using alternate age-points
for childhood socioeconomic position (11 rather than 4 years),
young adulthood (36 rather than 26 years) and middle age (43
rather than 53 years); these changes did not materially affect the
results or conclusions. Results using multiple imputation were
similar to those using complete case analysis (Supplementary
Table 4), except that associations between socioeconomic posi-
tion, interleukin-6 and proinsulin were still apparent after adjust-
ment for current and life course body mass index.
4. Discussion
4.1. Main ﬁndings
In this prospective birth cohort study, and using novel analytic
approaches, we observed that low socioeconomic position inTable 4
Selected life course social class model for each novel coronary heart disease (CHD) risk m
Model 1 Model 2 Model 3
Sex and agea only Current smoking
(age 60e64)
Life cours
(ages 20e
Childhood sensitive period model (manual vs non-manual social class in childhoo
Interleukin-6 (N ¼ 1144) 12.2 9.3 8.8
(4.0e20.4) (1.0e17.5) (0.5e17.0
Leptin (N ¼ 1147) 16.7 18.4 15.6
(7.6e25.9) (9.2e27.6) (6.4e24.9
Childhood þ early adulthood accumulation model (each additional time in manu
C-reactive protein (N ¼ 1151) 16.3 13.8 13.6
(9.6e23.0) (6.9e20.6) (6.7e20.5
E-selectin (N ¼ 1144) 2.4 2.4 1.5
(1.0 to 5.8) (1.1 to 5.9) (1.9 to 5
Proinsulin (N ¼ 1018) 10.7 11.4 8.7
(5.3e16.1) (5.9e17.0) (3.2e14.2
a Age at blood draw (60e64 years).childhood was associated with higher values of several novel CHD
risk factors, including C-reactive protein, interleukin-6, leptin and
proinsulin at 60e64 years. In addition, socioeconomic position in
young adulthood was also important for C-reactive protein and
proinsulin, suggesting the possibility of cumulative effects oper-
ating across childhood and early adult life. These associations were
attenuated considerably by adjustment for body mass index and, to
a lesser extent cigarette smoking, suggesting that body mass index
in particular may be an important mediator of the relationship
between socioeconomic position and these novel CHD risk factors.
4.2. Comparison with previous ﬁndings
Several studies have reported associations between low socio-
economic position and higher levels of inﬂammatory and endo-
thelial function markers such as C-reactive protein, interleukin-6
and tissue plasminogen activator, which are consistent with those
reported in the present study [16e18,34]. However, most previous
studies investigated socioeconomic position at a single time point,
usually in adult life; few have investigated different life course
models such as sensitive period or accumulation of risk models
[6,16,33]; those which have did not attempt to distinguish between
them or to identify a best ﬁtting model. Both the Framingham
Offspring Study and the 1958 British Birth Cohort reported that
lower cumulative socioeconomic position over the life course was
related to higher levels of C-reactive protein [6,35], as in the present
study. The former study showed that participants with low cu-
mulative socioeconomic position scores (father's education, own
education and own occupation) had higher C-reactive proteinarker adjusted for sex, age a and potential mediators.
Model 4 Model 5 Model 6
e smoking
53)
Current body mass
index (age 60e64)
Life course body mass
index (ages 4, 26 and 53)
All
d)
7.1 8.4 3.0
) (1.0 to 15.2) (0.2e16.6) (5.1 to 11.1)
0.6 4.8 2.4
) (6.4 to 7.6) (3.0 to 12.5) (4.6 to 9.4)
al vs non-manual social class)
11.3 13.5 8.2
) (4.7e17.8) (6.8e20.2) (1.4e15.0)
0.3 1.0 0.0
.0) (3.0 to 3.7) (2.4 to 4.4) (3.5 to 3.5)
3.8 6.0 3.9
) (1.0 to 8.6) (1.1e11.0) (1.0 to 8.8)
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adjustment for socioeconomic position at each of the other time
points only associations with childhood and early adult socioeco-
nomic position remained. Our results extend these earlier reports
by showing that the childhood and early adult accumulation model
displayed the best model ﬁt, while also showing that life course
accumulationmodels (both the childhood and early adulthood only
and the model with all three time points), explained the C-reactive
protein data as well as the saturated model. An earlier report from
the Young Finns Study [16] however found only a weak association
between parental socioeconomic position with C-reactive protein
levels; this may reﬂect the early age at outcome (24e39 years),
substantially earlier than in the present report.
As in our study, the Framingham Offspring Study found associ-
ations between childhood socioeconomic position and interleukin-
6 [6]; again, the present report extends this earlier observation by
showing that the childhood sensitive periodmodel was actually the
best ﬁtting model for interleukin-6. However, our observation that
socioeconomic position at any point in the life course was not
related to tissue plasminogen activator contrasts with a report from
the 1958 British Birth Cohort showing that childhood but not adult
socioeconomic positionwas related to tissue plasminogen activator
[35]. While the difference from our ﬁndings may reﬂect the sub-
stantially larger size and greater statistical power of the 1958
Cohort, our ﬁnding of a null association between socioeconomic
position and E-selectin, another key endothelial function marker,
supports the validity of our observation.
To our knowledge, this is the ﬁrst report on associations be-
tween life course socioeconomic position and proinsulin, leptin and
adiponectin. The presence of an association between childhood
socioeconomic position and leptin, rather than adiponectin, may
well reﬂect its stronger association with body fatness [36], which
shows a strong association with socioeconomic position from
childhood [37]. This would also be consistent with our ﬁnding that
adjustment for body mass index substantially reduced the associ-
ations between socioeconomic position and C-reactive protein,
interleukin-6, proinsulin and leptin, emphasizing an important
mediating role of body fatness in the association between socio-
economic position over the life course and novel CHD risk factors in
later life; consistent with observations in the 1958 British Birth
Cohort [35], and The Framingham Offspring Study [19].
4.3. Strengths and limitations
A major strength of this study is the availability of data on
several novel CHD risk factors representing several biological
pathways (inﬂammation, endothelial, adipocyte and pancreatic
beta function), measured in late middle age in a large birth cohort
with detailed historical records, permitting us to investigate the
role of socioeconomic position at different time points over the life
course. The structured modelling approach we used to compare
several different life course socioeconomic position models is an
improvement over traditional regression models where results are
interpreted from a single pre-speciﬁed model without considering
the merits of alternative models [7]. Although the approach has
limitations, including the requirement to merge the four socio-
economic position categories into two and to include notmore than
three age-groups, it does provide an indication of best ﬁtting life
course exposure patterns, although in some cases the distinction
between the best ﬁtting and the next best ﬁtting models is not
strong. However, in previous analyses, the results yielded by this
method matched socioeconomic trends seen in models with four
categories [7]. In addition, results were not materially affected by
the use of alternative age-points for socioeconomic position were
used, indicating that ﬁndings are likely to be robust to the inclusionof socioeconomic position at other ages. Although the analyses
presented are entirely based on the occupation of the male partner,
the present cohort was characterized by high rates of paternal
employment and by low rates of maternal employment, and by low
rates of separation and divorce, suggesting that the male occupa-
tional measure is likely to have been particularly appropriate in this
context.
Although the original birth cohort on which this investigation
was based was highly representative of the British population [29],
a relatively large proportion of our sample did not have complete
data (particularly on potential mediators of the relationship be-
tween socioeconomic position and CHD risk), raising the possibility
of selection bias. However, with detailed information on participant
characteristics from earlier phases of measurement, it was possible
to carry out robust multiple imputation analyses, speciﬁcally to
examine the impact of selection bias on the results observed. These
analyses did not materially affect the main results, but suggested
that the strength of the associations between socioeconomic po-
sition and these novel CHD risk factors, interleukin-6 in particular,
were slightly underestimated in the subsamplewith complete data.
4.4. Implications
The results suggest that childhood socioeconomic position,
acting either as a sensitive period effect or as part of a cumulative
life course model, is associated with several novel CHD risk factors
in later middle age. If the associations between these novel risk
factors and CHD are shown to be causal, as appears increasingly
likely for interleukin-6 [38] though not for C-reactive protein [39],
this would add weight to earlier suggestions that reducing socio-
economic inequalities in childhood could be particularly important
for the prevention of CHD in later life [40]. The strength of the
associations between socioeconomic position and CHD risk factors,
even if causal, would be too small to be clinically important. For
example, the increase in leptin level associated with being in a
manual rather than a non-manual social class group (~20%) would
be associated with an increase in the relative risk of coronary heart
disease of ~1e2% [12] at the individual level. However, such an
increase, if affecting the half of the study population in manual
occupations, could be of appreciable public health importance.
A second potentially important implication is the role played by
adult body fatness as a mediator of the associations between
childhood socioeconomic position and several novel CHD risk fac-
tors, particularly C-reactive protein, interleukin-6, proinsulin and
leptin. This suggests that targeted prevention and treatment of
overweight and obesity in low socioeconomic groups, particularly
at a population level and throughout the life course, could play a
particularly important role in reducing socioeconomic inequalities
in CHD in adult life.
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